Galectin Therapeutics
GALT
#8462
Rank
NZ$0.49 B
Marketcap
NZ$4.92
Share price
-4.27%
Change (1 day)
-48.39%
Change (1 year)

EPS for Galectin Therapeutics (GALT)

EPS in 2026 (TTM): NZ-$0.81

According to Galectin Therapeutics's latest financial reports the company's current EPS (TTM) is NZ-$0.86. In 2025 the company made an earnings per share (EPS) of NZ-$0.88 an increase over its 2024 EPS that were of NZ-$1.39.

EPS history for Galectin Therapeutics from 2001 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$0.81-8.04%
2025NZ-$0.88-36.84%
2024NZ-$1.392.7%
2023NZ-$1.3513.85%
2022NZ-$1.1925%
2021NZ-$0.9526.83%
2020NZ-$0.755.13%
2019NZ-$0.712.63%
2018NZ-$0.69-22.45%
2017NZ-$0.90-35.53%
2016NZ-$1.39-13.64%
2015NZ-$1.6112.82%
2014NZ-$1.43-40%
2013NZ-$2.3880.56%
2012NZ-$1.32-32.08%
2011NZ-$1.9413.98%
2010NZ-$1.70-22.5%
2009NZ-$2.19185.71%
2008NZ-$0.77-70.83%
2007NZ-$2.63118.18%
2006NZ-$1.21-54.17%
2005NZ-$2.63-14.29%
2004NZ-$3.0747.37%
2003NZ-$2.08-13.64%
2002NZ-$2.41-24.14%
2001NZ-$3.18

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Mirati Therapeutics
MRTX
NZ-$22.34 2,500.00%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
NZ-$0.24-72.34%๐Ÿ‡บ๐Ÿ‡ธ USA